MAP1LC3A and type 2 diabetes mellitus: The increased risk of type 2 diabetes was significantly associated with the MAP1LC3A expression in various tissues such as the pancreas (Z = 2.4, Q = 0.008), skeletal muscle (Z = 2.5, Q = 0.006), adipose tissue (Z = 2.4, Q = 0.008), and whole blood (Z = 2.3, Q = 0.01).